Current treatments in diabetic macular oedema: systematic review and meta-analysis

John Alexander Ford, Noemi Lois, Pamela Royle, Christine Clar, Deepson Shyangdan, Norman Waugh

Research output: Contribution to journalArticlepeer-review

89 Citations (Scopus)


The aim of this systematic review is to appraise the evidence for the use of anti-VEGF drugs and steroids in diabetic macular oedema (DMO) as assessed by change in best corrected visual acuity (BCVA), central macular thickness and adverse events
Original languageEnglish
Article numbere002269
JournalBMJ Open
Issue number3
Publication statusPublished - 1 Mar 2013

Cite this